Delivery Order SPE2DB22D1017-SPE2DB24FG5BE

Award Date 9/12/24
Potential Completion Date 10/3/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of medical commodities to the U.S. military. The $4,530.60 delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance ending on September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,530.60 firm fixed price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm-fixed-price delivery order is for the supply of the medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through June 5, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $4,530.60 firm-fixed-price delivery order contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty medication. The contract is not set aside and has an ultimate completion date of October 15, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,530.60 firm fixed-price delivery order is for TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty medication. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,530.60 firm fixed-price delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 firm-fixed-price delivery order has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $4,530.60 delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a period of performance through July 2025. The contract is not set-aside and allows for the provision of a range of pharmaceutical and medical products to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,343.59 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a period of performance ending on July 10, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG5BE
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,530.60 firm-fixed-price delivery order is for the supply of the medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/12/24, 9:03 AM